IDIQ for cancer therapy drugs: lutathera and pluvicto

Active Indefinite Delivery Contract Awarded Last action

Contract number
W81K0024D0004
Awardee
Awarding agency
Task orders
3 $6,619,099 obligated

Award facts

Opportunity
Combined order value
$11,988,584 Current and potential, with all options
Last date to order 41% complete
IDV ceiling 25% used
$26,095,049.21
Award type
Single award
Who can order
Only the awarding agency
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

The Defense Health Agency awarded a single-award Indefinite Delivery Contract to Novartis Pharmaceuticals Corporation on October 1, 2024, with a ceiling value of $26.1 million extending through September 30, 2029. This contract vehicle procures two specialized radiopharmaceutical cancer therapies: LUTATHERA (Lutetium Lu-177 dotatate) and PLUVICTO (Lutetium Lu-177 vipivotide tetraxetan), which are advanced oncology treatments utilized in nuclear medicine applications for cancer patient care within the federal healthcare system. The contract originated from a pre-solicitation notice issued by the Army Medical Command in April 2024 under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and authorizes firm fixed-price line items for deliveries spanning the five-year performance period. No small business set-aside was utilized, enabling Novartis to compete directly in the federal marketplace as a large pharmaceutical manufacturer.

Two delivery orders have been issued under this Indefinite Delivery Contract as of the provided documentation. The initial delivery order, awarded October 1, 2024, carried a ceiling value of $3.39 million for performance through September 30, 2025, with delivery to Fort Sam Houston, Texas, and utilized fixed-price with economic price adjustment pricing. A subsequent fiscal year 2026 delivery order awarded October 1, 2025, carries a ceiling value of $3.18 million for the period October 1, 2025 through September 30, 2026, also with performance at Fort Sam Houston. These delivery orders authorize procurement of both LUTATHERA and PLUVICTO under CLINs 0001 and 0002, supporting the Department of Defense medical treatment mission and federal healthcare delivery to military personnel and their families through military treatment facilities.

Task orders

Task order Ordering agency Obligated Awarded
Clin 2001AA and clin 2001AB W81K0026FA128 Medical Command (Army) $0
Lutathera and pluvicto W81K0025FA195 Medical Command (Army) $3,232,080
Delivery order for pluvicto and lutathera W81K0024F0177 Medical Command (Army) $3,387,020

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00003 · Modified quantities for slins 1001AA and 1001AB for ordering period from 1 OCT 25 to 31 DEC 25 whereas slins 1001AC and 1001AD had updated unit pricing and… $0
Novation Agreement P00002 · Novation agreement $0
Funding Only Action P00001 · Lutetium LU-177 vipivotide tetraxetan $0
Original award $0

Quick answers

Who was awarded contract W81K0024D0004?

W81K0024D0004 was awarded to Novartis Pharmaceuticals Corporation by Medical Command (Department of the Army) on October 1, 2024.

How much is contract W81K0024D0004 worth?

Orders under W81K0024D0004 have obligated $6,619,099. Their combined current value, with exercised options, is $11,988,584. W81K0024D0004's own ceiling is $26,095,049.

How many orders have been placed under contract W81K0024D0004?

3 orders have been placed under W81K0024D0004, the latest on October 1, 2026.

Which agency awarded contract W81K0024D0004?

Medical Command (Department of the Army) awarded W81K0024D0004, with funding from Defense Health Agency (Department of Defense).

Who can order from contract W81K0024D0004?

W81K0024D0004 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract W81K0024D0004 competed?

The extent of competition for W81K0024D0004 was not competed. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV